Related Experiment Video
Updated: Jul 13, 2026
04:41
Treatment with Locking Intramedullary Nailing for Intertrochanteric Fracture of the Femur Utilizing a New Awl with a Distal Positioner
Published on: June 6, 2025
[Pertrochanteric fractures in elderly subjects aged over 75]
D Waast1, D Touraine, L Wessely
1Service d'Orthopédie, CHU, Hôtel-Dieu, Nantes.
Summary
Pertrochanteric fractures in elderly patients require careful surgical treatment. Good outcomes depend on reduction quality and osteosynthesis, not implant type, highlighting the need for osteoporosis prevention.
Area of Science:
- Geriatric Orthopedics
- Trauma Surgery
- Public Health
Background:
- Pertrochanteric fractures are a significant public health issue, particularly in elderly populations.
- Evaluating treatment outcomes for these fractures is crucial for improving patient care.
- Osteoporosis significantly contributes to fracture risk in older adults.
Framework:
- This retrospective, multicenter study analyzed patients over 75 with pertrochanteric fractures.
- Data was collected from five university hospitals over a one-year period (May 2004-May 2005).
- Key outcome measures included the quality of fracture reduction and osteosynthesis positioning.
Implementation:
- Surgical treatment outcomes were assessed based on predefined criteria.
- The influence of different implant materials on patient outcomes was examined.
- Clinical data was gathered retrospectively from participating institutions.
Implications:
- The quality of surgical reduction and implant placement are primary determinants of successful pertrochanteric fracture treatment.
- Implant material choice has minimal impact on patient outcomes.
- Effective osteoporosis prevention and management are critical for reducing fracture incidence and improving prognosis, even post-fracture.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...